Interview with Nick Coupe on the Importance of Melanoma Awareness

Dr Nick Coupe, a consultant at the Churchill hospital, has been talking to That’s TV Oxfordshire about the importance of Melanoma awareness. This May, Skin Cancer Awareness Month, we are producing a series of blogposts to highlight what’s going on in Oxford to tackle skin cancer. Skin cancer is a cancer where rates are rising, here Nick talks about what we should all look out for and the promising research emerging from leading cancer research centres such as the Oxford Cancer Network.

Watch Nick’s interview here:

Find out more about our research below

Cancer immunologist Lieping Chen joins Ludwig Oxford as a Visiting Professor

Oxford is delighted to welcome this acclaimed scientist to the Branch and the Ludwig Oxford community.

Using Herpesvirus to fight cancer

The Seymour lab at the Department of Oncology, University of Oxford, has published a new paper investigating the use of oncolytic herpes virus-1 as a vector to augment immunotherapy in cancer

T-cell landscape mapping identifies new targets for pancreatic cancer immunotherapy

Through analysis of T-cell populations, Oxford pancreatic researchers identify novel therapeutic opportunities in pancreatic cancer patients
Doctor looking at skin

Higher testosterone levels in men linked to greater melanoma risk

New research from Dr Eleanor Watts at the Nuffield Department of Population Health has found this association for the first time

DeLIVER clinical research study underway as recruitment opens

The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.

Prof Andi Roy receives new award for immune-cell research

Co-funded by Cancer Research UK and Children with Cancer UK, Andi is one of 5 to receive £1 million each to investigate children’s and young people’s cancers.
An animated drawing of a syringe releasing contents that attacks cancer cells

Improving immunotherapy through epigenetics

Professor Yang Shi’s group uses combination therapy to eradicate tumours that previously responded poorly to immunotherapy
Christina Ye

Christina Ye awarded CRUK pre-doctoral fellowship

Christina Ye has been awarded CRUK pre-doctoral fellowship, she tells us about her upcoming project into T cell trafficking between the blood and skin when patients undergo checkpoint immunotherapy

New melanoma drug a step closer to the clinic

Clinical trials into the use of Tebentafusp for metastatic uveal melanoma have been conducted by the University of Oxford and Immunocore. The positive results of the most recent trial mean this drug could now be used in future treatment.